Form D · Other Technology
TRILLIANT HEALTH, INC.
Nashville, TN · CIK 0001748660
Offering snapshot reported Aug 8, 2018 · SEC filing
- Reported sold
- $12.7M Offering amount: $14.4M
- Investors reported
- 32 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 26, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 8, 2018 | Initial | $12,665,774 | No comparison | 32 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-318688
Amounts rounded to nearest dollar. The numbers listed include the amount of indebtedness under notes that were converted in the offering.
Source: Form D, filed Aug 8, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hal Andrews | Director, Executive |
| Mark Bacurin | Executive |
| Devin Carty | Director |
| Will Fitzgibbon | Director |
| Rick Hernandez | Director |
| Charles Martin, Jr. | Director |
| W. Spence Mcclelland | Director |
| Henry Ross | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
8 Cadillac Drive Suite 450
Nashville, TN, 37027
Nashville, TN, 37027